Clinical Trial Update: The Effect of Testosterone Topical Solution (LY900011) in Hypogonadal Men With Suboptimal Response to a Topical Testosterone Gel [Phase 4]

View source ↗

Summary

This Phase 4 trial investigated a testosterone topical solution (LY900011) in hypogonadal men with suboptimal response to a testosterone gel; the study complete…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypogonadism

Drugs mentioned

• Testosterone topical solution LY900011 (testosterone)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Hypogonadism | Phase 4 | Status: COMPLETED | Results posted: 2014-10-27